Heparin investigation focuses on raw ingredients

Los Angeles Times: "WASHINGTON -- The investigation into a blood thinner suspected in some 19 U.S. deaths is now focusing on the possibility that raw biological ingredients were contaminated even before they reached a factory in China, manufacturer Baxter Healthcare Corp. said Friday."